ConductScience.org, home

Paper8698485

Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.

Daly TM and 1 other. Infect Immun, 1996. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Papers, record 8698485. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8698485

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.
PubMed
Journal
Infect Immun
PubMed
Year
1996
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.21
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daly TMT M
2Long CAC A

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Antigens, ProtozoanMajor topic
MalariaMajor topic
Plasmodium yoeliiMajor topic
Protein PrecursorsMajor topic
Protozoan ProteinsMajor topic
Animals
Antibodies, Protozoan
Immunization
Immunoglobulin Isotypes
Malaria Vaccines
Male
Merozoite Surface Protein 1
Mice
Mice, Inbred BALB C
Recombinant Fusion Proteins
Species Specificity
Vaccines, Synthetic

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AI-21089NIAID NIH HHSUnited StatesR01AI021089PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18363656A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.Infect Immun1993https://conductscience.org/library/papers/8363656PubMed
28577318Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum.Mol Biochem Parasitol1995https://conductscience.org/library/papers/8577318PubMed
38515786Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates.Mol Biochem Parasitol1993https://conductscience.org/library/papers/8515786PubMed
47687586Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.Infect Immun1993https://conductscience.org/library/papers/7687586PubMed
58216931Immunity to blood stages of malaria.Curr Opin Immunol1993https://conductscience.org/library/papers/8216931PubMed
67694147Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.Mol Biochem Parasitol1993https://conductscience.org/library/papers/7694147PubMed
78258712Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.J Immunol1993https://conductscience.org/library/papers/8258712PubMed
88144929Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.J Immunol1994https://conductscience.org/library/papers/8144929PubMed
98172332Copolymer adjuvants in malaria vaccine development.Am J Trop Med Hyg1994https://conductscience.org/library/papers/8172332PubMed
107516416Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.J Exp Med1994https://conductscience.org/library/papers/7516416PubMed
118015856Immunization against malaria with a recombinant protein.Parasite Immunol1994https://conductscience.org/library/papers/8015856PubMed
127312033Immunization against blood-stage rodent malaria using purified parasite antigens.Nature1981https://conductscience.org/library/papers/7312033PubMed
136652973Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.Clin Exp Immunol1983https://conductscience.org/library/papers/6652973PubMed
146725950Passive immunization against murine malaria with an IgG3 monoclonal antibody.J Immunol1984https://conductscience.org/library/papers/6725950PubMed
153540125An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.J Immunol Methods1986https://conductscience.org/library/papers/3540125PubMed
163554251Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3554251PubMed
172448778The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2448778PubMed
183047011Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.Gene1988https://conductscience.org/library/papers/3047011PubMed
192524278Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses.Cell Immunol1989https://conductscience.org/library/papers/2524278PubMed
202474611Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies.J Immunol Methods1989https://conductscience.org/library/papers/2474611PubMed

See all 38 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
26380320Differential Immune Response against Recombinant Leishmania donovani Peroxidoxin 1 and Peroxidoxin 2 Proteins in BALB/c Mice.J Immunol Res2015https://conductscience.org/library/papers/26380320PubMed
23897613A chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodies.Infect Immun2013https://conductscience.org/library/papers/23897613PubMed
21820475A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1.Vaccine2011https://conductscience.org/library/papers/21820475PubMed
21603205Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?J Parasitol Res2011https://conductscience.org/library/papers/21603205PubMed
20709001Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection.Vaccine2010https://conductscience.org/library/papers/20709001PubMed
19917716Growth-inhibitory antibodies are not necessary for protective immunity to malaria infection.Infect Immun2010https://conductscience.org/library/papers/19917716PubMed
19250541AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5.Malar J2009https://conductscience.org/library/papers/19250541PubMed
18486913Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment.Int Immunopharmacol2008https://conductscience.org/library/papers/18486913PubMed
17158895Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.Infect Immun2007https://conductscience.org/library/papers/17158895PubMed
16177307Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.Infect Immun2005https://conductscience.org/library/papers/16177307PubMed
15385477Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.Infect Immun2004https://conductscience.org/library/papers/15385477PubMed
15385457Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.Infect Immun2004https://conductscience.org/library/papers/15385457PubMed
14742548Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.Infect Immun2004https://conductscience.org/library/papers/14742548PubMed
12496191Roles of the Maltese cross form in the development of parasitemia and protection against Babesia microti infection in mice.Infect Immun2003https://conductscience.org/library/papers/12496191PubMed
11067879Antigen-specific T helper cell function: differential cytokine expression in primary and memory responses.J Exp Med2000https://conductscience.org/library/papers/11067879PubMed
11027434A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1.Br J Cancer2000https://conductscience.org/library/papers/11027434PubMed
10722607
Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
Infect Immun2000https://conductscience.org/library/papers/10722607PubMed
9864235Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.Infect Immun1999https://conductscience.org/library/papers/9864235PubMed
9784540Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1.Infect Immun1998https://conductscience.org/library/papers/9784540PubMed
9673281Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia.Infect Immun1998https://conductscience.org/library/papers/9673281PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8698485

GET https://conductscience.org/api/papers/v1/8698485/references?page=2